相关实验视频

Updated: Jul 1, 2025

Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture

Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture

Published on: April 8, 2016

针对抗IL-23生物药物的p19向的结构基础:与牛皮的短期和长期疗效的相关性

Stefano G Daniele¹, Sherif A Eldirany², Giovanni Damiani^3,4,5

¹MD-PhD Program, Yale School of Medicine, New Haven, Connecticut, USA.

JID innovations : skin science from molecules to population health

|March 6, 2024

概括

干白素-23 (IL-23) 抑制剂在牛皮中表现出不同的临床疗效. 皮层表面积,结合亲和力和解离率与治疗成功相关,解释了IL-23生物制剂之间的差异.

科学领域:

免疫学免疫学免疫学
皮肤病学皮肤病学
结构生物学结构生物学

背景情况:

介素-23 (IL-23) 是牛皮发育的一个关键驱动因素.
针对IL-23的生物药物是有效的牛皮治疗方法,但它们的不同临床疗效尚未完全理解.
目前的IL-23抑制剂包括p19亚单元结合剂 (risankizumab,tildrakizumab,guselkumab) 和一个p40结合剂 (ustekinumab).

研究的目的:

研究IL-23抑制剂表位的结构和分子特性.
为了将这些表位特征与结合动力学和斑块牛皮的临床疗效相关联.
解释IL-23生物物种中观察到的不同临床反应.

主要方法:

使用-交换或晶体学数据进行皮层映射.
对表位位置,疏水性,表面电荷和溶剂可访问的表面积的分析.
线性回归分析将分子特性与结合亲和力 (K_D,k_on,k_off) 和临床疗效相关联 (PASI-90).

主要成果:

每个IL-23抑制剂都针对IL-23表面的一个独特的表位.
皮层表面积与结合亲和力 (K_D) 和解离率 (k_off) 有着强烈的相关性,但与结合率 (k_on) 没有相关性.
较大的表位表面积,较低的K_D和较低的k_off与较高的短期和长期PASI-90反应有关,而risankizumab显示出最大的疗效.

结论:

IL-23抑制剂表位的分子特性,特别是表面积,显著影响结合动力学和临床疗效.
皮层表面积和相关的结合参数解释了IL-23生物药物治疗牛皮的不同疗效.
这项研究为IL-23向治疗的不同临床结果提供了分子洞察力.

关键词:

在Guselkumab的房间里.炎症性皮肤疾病的表位是炎症性皮肤疾病.冒着危险的生命危险.提尔德拉基祖马巴姆 (Tildrakizumab) 是一个乌斯特基诺姆巴布 (乌斯特基诺姆巴布) 是一个

更多相关视频

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

Published on: September 26, 2013

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

相关概念视频

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...